Lu AG06466

DRUG9 trials

Sponsors

H. Lundbeck A/S

Conditions

FibromyalgiaFocal EpilepsyHealthyHealthy ParticipantsHealthy VolunteersMultiple SclerosisPTSD

Phase 1

Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women

CompletedNCT04405323

H. Lundbeck A/SHealthy

Start: 2020-05-20End: 2020-07-28Updated: 2020-08-14

Binding of Lu AG06466 in the Brain in Healthy Men

CompletedNCT04419636

H. Lundbeck A/SHealthy

Start: 2020-05-29End: 2021-02-16Updated: 2021-02-24

Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)

CompletedNCT04597450

H. Lundbeck A/SPTSD

Start: 2020-09-30End: 2023-02-13Updated: 2023-03-24

Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men

CompletedNCT04713254

H. Lundbeck A/SHealthy

Start: 2020-12-08End: 2021-04-09Updated: 2021-04-20

A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

TerminatedNCT04974359

H. Lundbeck A/SFibromyalgia

Start: 2021-06-24End: 2022-01-26Updated: 2022-02-11

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

TerminatedNCT04990219

H. Lundbeck A/SMultiple Sclerosis

Start: 2021-09-27End: 2023-01-31Updated: 2023-02-03

A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

TerminatedNCT05081518

H. Lundbeck A/SFocal Epilepsy

Start: 2021-09-29End: 2022-04-14Updated: 2022-11-09

Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants

TerminatedNCT05177029

H. Lundbeck A/SHealthy Volunteers

Start: 2021-11-26End: 2021-12-29Updated: 2022-07-12

Binding and Effects of Lu AG06466 in the Brain of Healthy Men

CompletedNCT05219838

H. Lundbeck A/SHealthy Participants

Start: 2022-01-18End: 2022-08-29Updated: 2022-09-09